MA30882B1 - Derives d'acides vinylogues en tant qu'inhibiteur de la chymase - Google Patents

Derives d'acides vinylogues en tant qu'inhibiteur de la chymase

Info

Publication number
MA30882B1
MA30882B1 MA31862A MA31862A MA30882B1 MA 30882 B1 MA30882 B1 MA 30882B1 MA 31862 A MA31862 A MA 31862A MA 31862 A MA31862 A MA 31862A MA 30882 B1 MA30882 B1 MA 30882B1
Authority
MA
Morocco
Prior art keywords
acid derivatives
vinylogic
chymase inhibitor
chymase
inhibitor
Prior art date
Application number
MA31862A
Other languages
English (en)
Inventor
David Banner
Hans Hilpert
Bernd Kuhn
Harald Mauser
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA30882B1 publication Critical patent/MA30882B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

L'INVENTION CONCERNE DE NOUVEAUX DÉRIVÉS D'ACIDES VINYLOGUES REPRÉSENTÉS PAR LA FORMULE (I) DANS LAQUELLE A ET R1 À R5 SONT TELS QUE DÉFINIS DANS LA DESCRIPTION ET DANS LES REVENDICATIONS, AINSI QUE DES SELS PHYSIOLOGIQUEMENT ACCEPTABLES DE CES DÉRIVÉS. CES COMPOSÉS INHIBENT LA CHYMASE ET PEUVENT ÊTRE UTILISÉS COMME MÉDICAMENTS.
MA31862A 2006-10-13 2009-05-11 Derives d'acides vinylogues en tant qu'inhibiteur de la chymase MA30882B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06122239 2006-10-13

Publications (1)

Publication Number Publication Date
MA30882B1 true MA30882B1 (fr) 2009-11-02

Family

ID=38728675

Family Applications (1)

Application Number Title Priority Date Filing Date
MA31862A MA30882B1 (fr) 2006-10-13 2009-05-11 Derives d'acides vinylogues en tant qu'inhibiteur de la chymase

Country Status (21)

Country Link
US (1) US7705034B2 (fr)
EP (1) EP2074090A1 (fr)
JP (1) JP4976499B2 (fr)
KR (1) KR101122989B1 (fr)
CN (1) CN101522615A (fr)
AR (1) AR063269A1 (fr)
AU (1) AU2007306399B2 (fr)
BR (1) BRPI0719785A2 (fr)
CA (1) CA2665046A1 (fr)
CL (1) CL2007002922A1 (fr)
CR (1) CR10678A (fr)
IL (1) IL197764A0 (fr)
MA (1) MA30882B1 (fr)
MX (1) MX2009003640A (fr)
NO (1) NO20091255L (fr)
NZ (1) NZ575741A (fr)
PE (1) PE20081176A1 (fr)
RU (1) RU2451013C2 (fr)
TW (1) TWI337864B (fr)
UA (1) UA96610C2 (fr)
WO (1) WO2008043698A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI501962B (zh) 2009-12-25 2015-10-01 Daiichi Sankyo Co Ltd 7-membered ring compounds and their pharmaceutical use

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982000032A1 (fr) 1980-06-25 1982-02-07 Tsuchiya M Procede de preparation d'indoles
US4443615A (en) * 1981-11-10 1984-04-17 Tanabe Seiyaku Co., Ltd. Process for preparing indoles
AU7855787A (en) 1986-08-08 1988-02-24 Upjohn Company, The Asymmetric synthesis of enantiomerically pure monocyclic beta-lactam intermediates
JPH0578250A (ja) 1991-09-18 1993-03-30 Fujisawa Pharmaceut Co Ltd 肝炎または膵炎の予防・治療剤
AU668180B2 (en) 1992-05-20 1996-04-26 Merck & Co., Inc. 17-ethers and thioethers of 4-aza-steroids
JPH07508039A (ja) 1992-05-20 1995-09-07 メルク　エンド　カンパニー　インコーポレーテッド ４−アザステロイドのエステル誘導体
GB9418762D0 (en) 1994-09-16 1994-11-02 Bayer Ag Use of substituted cyclopentane-DI-and-triones
EP0795548B1 (fr) * 1995-09-28 2002-07-03 Suntory Limited Derives de la quinazoline et leurs emplois
US6271238B1 (en) * 1996-09-06 2001-08-07 Nippon Kayaku Kabushiki Kaisha Acetamide derivatives and protease inhibitors
TR200002760T2 (tr) 1998-03-27 2000-12-21 Janssen Pharmaceutica N.V. HIV engelleyici pirimidin türevleri
AU4654199A (en) * 1998-07-23 2000-02-14 Shionogi & Co., Ltd. Monocyclic beta-lactam compounds and chymase inhibitors containing the same
EP1136488A4 (fr) 1998-12-01 2002-06-12 Meiji Seika Kaisha Substances sf2809-i, ii, iii, iv, v et vi presentant une activite d'inhibition de la chymase
US6444686B1 (en) 1998-12-18 2002-09-03 Brsitol-Myers Squibb Pharma Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
EP1167360A1 (fr) * 2000-01-17 2002-01-02 Teijin Limited Inhibiteurs de chymase humaine
US7205318B2 (en) 2003-03-18 2007-04-17 Bristol-Myers Squibb Company Lactam-containing cyclic diamines and derivatives as a factor Xa inhibitors

Also Published As

Publication number Publication date
JP2010505900A (ja) 2010-02-25
TW200824685A (en) 2008-06-16
CN101522615A (zh) 2009-09-02
AU2007306399B2 (en) 2012-05-17
RU2009117707A (ru) 2010-11-20
PE20081176A1 (es) 2008-09-17
JP4976499B2 (ja) 2012-07-18
RU2451013C2 (ru) 2012-05-20
CR10678A (es) 2009-06-25
KR20090067165A (ko) 2009-06-24
WO2008043698A1 (fr) 2008-04-17
MX2009003640A (es) 2009-04-22
US7705034B2 (en) 2010-04-27
US20080096953A1 (en) 2008-04-24
CA2665046A1 (fr) 2008-04-17
NZ575741A (en) 2011-12-22
KR101122989B1 (ko) 2012-03-13
AR063269A1 (es) 2009-01-14
CL2007002922A1 (es) 2008-05-30
EP2074090A1 (fr) 2009-07-01
BRPI0719785A2 (pt) 2014-11-25
IL197764A0 (en) 2009-12-24
NO20091255L (no) 2009-04-27
TWI337864B (en) 2011-03-01
AU2007306399A1 (en) 2008-04-17
UA96610C2 (ru) 2011-11-25

Similar Documents

Publication Publication Date Title
MA30162B1 (fr) Nouveaux derives de pyrrole a cycles fusionnes
MA31574B1 (fr) Dérivés de pyrazole et leur utilisation comme inhibiteurs de raf
MA31000B1 (fr) Derives 2-aza-bicyclo[3.1.0]hexane
MA33364B1 (fr) Dérivés aminobutyriques substitués en tant qu'inhibiteurs de néprilysine
TN2009000428A1 (fr) Derives de sulfonylamides destines au traitement d'une croissance cellulaire anormale
MA31741B1 (fr) Derives fongicides de 2-alkylthio-2-quinolinyloxy- acetamide
MA29909B1 (fr) Derives de pyridazine
MA27559A1 (fr) Nouveaux derives de fluorglycoside aromatiques, produits pharmaceutiques contenant ces composes et leur utilisation
MA31080B1 (fr) Dérivés cyclisés en tant qu'inhibiteurs d'eg-5.
MA30717B1 (fr) Derives de pyridin-3-yle en tant qu'agents immunomodulateurs
MA30718B1 (fr) Derives de pyridin-4-yle en tant qu'agents immunomodulateurs.
MA31979B1 (fr) (cyclopropylphenyl) phenyloxamides, leur procede de production et leur utilisation comme medicament
MA27560A1 (fr) Nouveaux derives de fluorglycoside heterocycliques, produits pharmaceutiques contenant ces composes et leur utilisation
MA33275B1 (fr) Inhibiteurs de la replication du virus de l'immunodeficience humaine
MA32151B1 (fr) Derives de 2-aza-bicyclo[2.2.1]heptane
MA31690B1 (fr) Nouveaux fongicides
MA33886B1 (fr) Dérivés substitués d'acide carbamoylméthylamino-acétique utilisés comme nouveaux inhibiteurs de nep
MA32882B1 (fr) Nouveaux pyrazole-4-n-alkoxycarboxamides en tant que microbiocides
MA30988B1 (fr) Composes destines a inhiber la progression mitotique
MA31597B1 (fr) Nouveaux herbicides
MA33178B1 (fr) Pipéridines substituées comme antagonistes de ccr3
MA34340B1 (fr) Composes heteroaryles contenant de l'azote
MA30781B1 (fr) Inhibiteur de kinase
MA30784B1 (fr) Derives phenyliques et utilisation de ceux-ci en tant qu'immunomodulateurs.
MA31373B1 (fr) Composes amino-heterocycliques